Stay updated on Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:58:26.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added revision tag v3.5.0 and removed revision tag v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:28:44.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible content changes are indicated.
    Difference
    0.0%
    Check dated 2026-03-11T17:20:48.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Added Gastric Cancer to the related topics section and included Genetic and Rare Diseases Information Center as a resources reference.
    Difference
    0.1%
    Check dated 2026-02-18T09:04:18.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Site updated to revision v3.4.2; a government funding/status notice previously shown (v3.4.1) has been removed.
    Difference
    0.3%
    Check dated 2026-02-11T10:57:49.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with updated operating status for the NIH Clinical Center and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T06:37:06.000Z thumbnail image

Stay in the know with updates to Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Pembrolizumab Combo in HER2(+) Gastric Cancer Clinical Trial page.